Yondelis

Trabectedin (Yondelis) is an intravenous chemotherapy medication used for soft tissue sarcoma and ovarian cancer. It works by interfering with cancer cell growth. This prescription drug is administered by healthcare professionals in clinical settings.

Trabectedin is used to treat certain types of cancer, including soft tissue sarcoma and ovarian cancer. It is typically prescribed when other treatments have not been effective. Patients often ask, 'what is trabectedin used for' to understand its role in cancer therapy. It may also be used in combination with other medications for specific cases.

Trabectedin works by slowing or stopping the growth of cancer cells in the body. Patients may experience effects such as nausea, fatigue, or changes in blood cell counts during treatment. These effects are monitored closely by healthcare providers to ensure safety and adjust care as needed.

Trabectedin is a potent medication that should only be handled and administered by trained healthcare professionals. Patients must disclose their full medical history, including liver or kidney conditions, before starting treatment. Regular blood tests are required to monitor for potential side effects and adjust dosing as necessary.

Trabectedin can interact with other medications, including strong CYP3A inhibitors and inducers, which may affect its effectiveness or increase side effects. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using. Alcohol and certain supplements may also interact with trabectedin.